Pnv-select Tablet, Film Coated
NDC Package 42192-320-30
Package Information
Pnv-select (vitamin a acetate, ascorbic acid, cholecalciferol, alpha-tocopherol acetate, dl, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, calcium carbonate, ferrous fumarate, potassium iodide, magnesium oxide, zinc oxide and cupric oxide) tablets is a medication a multivitamin and iron product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. This formulation utilizes a tablet, film coated delivery system. Marketed by Acella Pharmaceuticals, Llc, this product is identified by NDC 42192-320.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 10 [iU]/1
- ASCORBIC ACID 80 mg/1
- BIOTIN 300 ug/1
- CALCIUM CARBONATE 120 mg/1
- CALCIUM PANTOTHENATE 6 mg/1
- CHOLECALCIFEROL 400 [iU]/1
- CUPRIC OXIDE 2 mg/1
- CYANOCOBALAMIN 12 ug/1
- FERROUS FUMARATE 27 mg/1
- FOLIC ACID 1 mg/1
- MAGNESIUM OXIDE 30 ug/1
- NIACINAMIDE 20 mg/1
- POTASSIUM IODIDE 150 ug/1
- PYRIDOXINE HYDROCHLORIDE 20 mg/1
- RIBOFLAVIN 3.4 mg/1
- THIAMINE MONONITRATE 3 mg/1
- VITAMIN A ACETATE 2500 [iU]/1
- ZINC OXIDE 15 ug/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 42192 - Acella Pharmaceuticals, Llc
- 42192-320 - Pnv-select
- 42192-320-30 - 30 TABLET, FILM COATED in 1 BOTTLE
- 42192-320 - Pnv-select
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42192-320). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42192-320-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Pnv-select, a human prescription drug labeled by Acella Pharmaceuticals, Llc. This tablet, film coated is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; biotin; calcium carbonate; calcium pantothenate; cholecalciferol; cupric oxide; cyanocobalamin; ferrous fumarate; folic acid; magnesium oxide; niacinamide; potassium iodide; pyridoxine hydrochloride; riboflavin; thiamine mononitrate; vitamin a acetate; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Acella Pharmaceuticals, Llc on October 01, 1990. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a multivitamin and iron product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. Vitamins and iron are important building blocks of the body and help keep you in good health.
How is this Acella Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42192032030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.